DEA Comes Out Of The Shadows To Ensure Cannabis Rescheduling Process Is Not Being Done Under 'Shroud Of Secrecy'
The DEA's silence beyond acknowledging the receipt of the U.S. Department of Health and Human Services (HHS) suggestion to reclassify marijuana has been a source of frustration for advocates and legislators, including co-chairs of the Congressional Cannabis Caucus Rep. Barbara Lee (D-CA) and Rep. Earl Blumenauer, (D-OR) who have complained about the DEA's lack of transparency.
